530 related articles for article (PubMed ID: 26170160)
1. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
[TBL] [Abstract][Full Text] [Related]
2. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
[TBL] [Abstract][Full Text] [Related]
3. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
4. The applicability of ordered mesoporous SBA-15 and its hydrophobic glutaraldehyde-bridge derivative to improve ibuprofen-loading in releasing system.
Rehman F; Volpe PL; Airoldi C
Colloids Surf B Biointerfaces; 2014 Jul; 119():82-9. PubMed ID: 24819430
[TBL] [Abstract][Full Text] [Related]
5. "Graft to" Synthesis and Ibuprofen-Loading Performance of pH-Sensitive PMAA-Silica Hybrid Nanoparticles with Controlled Bimodal Mesopores.
Han J; Sun J; Bai S; Panezai H; Jin X; Wu X
J Pharm Sci; 2015 Dec; 104(12):4299-4306. PubMed ID: 26501935
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel mesoporous silica nanoparticles for loading and release of ibuprofen.
Zhang H; Li Z; Xu P; Wu R; Wang L; Xiang Y; Jiao Z
J Control Release; 2011 Nov; 152 Suppl 1():e38-9. PubMed ID: 22195911
[No Abstract] [Full Text] [Related]
7. Mesoporous silica material TUD-1 as a drug delivery system.
Heikkilä T; Salonen J; Tuura J; Hamdy MS; Mul G; Kumar N; Salmi T; Murzin DY; Laitinen L; Kaukonen AM; Hirvonen J; Lehto VP
Int J Pharm; 2007 Feb; 331(1):133-8. PubMed ID: 17046183
[TBL] [Abstract][Full Text] [Related]
8. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
9. Amine bridges grafted mesoporous silica, as a prolonged/controlled drug release system for the enhanced therapeutic effect of short life drugs.
Rehman F; Ahmed K; Airoldi C; Gaisford S; Buanz A; Rahim A; Muhammad N; Volpe PLO
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():34-41. PubMed ID: 28024595
[TBL] [Abstract][Full Text] [Related]
10. In Situ Loading of Drugs into Mesoporous Silica SBA-15.
Wan MM; Li YY; Yang T; Zhang T; Sun XD; Zhu JH
Chemistry; 2016 Apr; 22(18):6294-301. PubMed ID: 26999658
[TBL] [Abstract][Full Text] [Related]
11. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
12. Variation of the crystal growth of mesoporous silica nanoparticles and the evaluation to ibuprofen loading and release.
Kamarudin NH; Jalil AA; Triwahyono S; Artika V; Salleh NF; Karim AH; Jaafar NF; Sazegar MR; Mukti RR; Hameed BH; Johari A
J Colloid Interface Sci; 2014 May; 421():6-13. PubMed ID: 24594025
[TBL] [Abstract][Full Text] [Related]
13. Synthesis Mechanism and Thermal Optimization of an Economical Mesoporous Material Using Silica: Implications for the Effective Removal or Delivery of Ibuprofen.
Kittappa S; Cui M; Ramalingam M; Ibrahim S; Khim J; Yoon Y; Snyder SA; Jang M
PLoS One; 2015; 10(7):e0130253. PubMed ID: 26161510
[TBL] [Abstract][Full Text] [Related]
14. Physical state of poorly water soluble therapeutic molecules loaded into SBA-15 ordered mesoporous silica carriers: a case study with itraconazole and ibuprofen.
Mellaerts R; Jammaer JA; Van Speybroeck M; Chen H; Van Humbeeck J; Augustijns P; Van den Mooter G; Martens JA
Langmuir; 2008 Aug; 24(16):8651-9. PubMed ID: 18630936
[TBL] [Abstract][Full Text] [Related]
15. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
[TBL] [Abstract][Full Text] [Related]
17. Submicron particles of SBA-15 modified with MgO as carriers for controlled drug delivery.
Shen S; Chow PS; Chen F; Tan RB
Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):985-91. PubMed ID: 17603186
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured SBA-15 host applied in ketorolac tromethamine release system.
Cussa J; Juárez JM; Gómez Costa MB; Anunziata OA
J Mater Sci Mater Med; 2017 Aug; 28(8):113. PubMed ID: 28625001
[TBL] [Abstract][Full Text] [Related]
19. Inclusion and release of fenbufen in mesoporous silica.
Carriazo D; del Arco M; Fernández A; Martín C; Rives V
J Pharm Sci; 2010 Aug; 99(8):3372-80. PubMed ID: 20232455
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional ultralarge-pore ia3d mesoporous silica with various pore diameters and their application in biomolecule immobilization.
Vinu A; Gokulakrishnan N; Balasubramanian VV; Alam S; Kapoor MP; Ariga K; Mori T
Chemistry; 2008; 14(36):11529-38. PubMed ID: 19006167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
